跳至主要内容
临床试验/DRKS00016917
DRKS00016917招募中未知

Evaluation of the value of PET/MRI for diagnosis and treatment monitoring of patients with ankylosing Spondylitis before and after Treatment with a TNF-blocker

MSD Deutschland0 个研究点目标入组 10 人开始时间: 2019年8月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Diagnosis of ankylosing spondylitis
  • Clinical indication for the onset of TNFa blocker therapy (BASDAI score of 4 despite prior treatment with at least 2 NSAIDs) over a period of at least one month
  • Adult patients with ankylosing spondylitis who are to receive 18F PET examination according to clinical indication
  • Written consent of the patient

排除标准

  • Contraindication to an MRI examination (strong Claustrophobia, Non-removable, ferromagnetic foreign bodies, Pacemakers / ICD)·
  • Contraindication to MRI contrast agents (High-grade renal insufficiency (GFR x 30 mg/dl; serum creatinine > 1.75 mg/dl))
  • Mental illness that limits understanding of the study protocol

研究者

发起方
MSD Deutschland

相似试验

Evaluation of the value of PET/MRI for diagnosis and... | 临床试验